Post

Finding a cure: How cell and gene therapies could revolutionise medicine

The potential for Advanced Therapy Medicinal Products (ATMPs) is transformational within healthcare, effectively providing the body with the tools to fix itself. ATMPs could offer cures for types of cancer, Alzheimer’s and haemophilia, or even help the patient’s brain to recover from a stroke. We speak to RoslinCT, an internationally recognised innovator in advanced therapeutics, to learn more about the medical breakthroughs under way in Scotland.

Poxel’s PXL770, PXL065 molecules receive EC orphan drug designation

Both PXL770 and PXL065 are currently preparing to enter Phase IIa clinical POC studies.

Money moves: How the biotech market is weathering inflationary storms

Kickstarting the Money Moves series, Pharmaceutical Technology looks at what the biotech market holds for the coming year.

The impact of clinical trial decentralisation on the pharma supply chain

Technological advancement has made decentralised trials more appealing than ever. The pharmaceutical industry must learn to adapt to their growing role

PROTACs show promise for cancer treatment

PROTACs have the potential to revolutionise the way we treat and study a wide range of diseases, by providing a highly specific and targeted means to manipulate the levels of specific proteins within cell.

Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition

Spikevax is an mRNA vaccine that is approved in 20 geographies including the US, EU, and, the UK.